Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Sankyo Company Limited

Agriculture


Contact Details:
5-1Nihonbashi Hon-cho 3-chome Chuo-ku
Tokyo
Tokyo
103
Japan
Tel:81 3 5255 7111
Fax:81 3 5255 7047
Email:
WWW:

www.sankyo.co.jp/




Recent Publications by Sankyo Company Limited:

Population pharmacokinetics of olmesartan following oral administration of its prodrug, olmesartan medoxomil: in healthy volunteers and hypertensive patients.
BACKGROUND: Olmesartan medoxomil (CS-866) is a new orally active...
12th August, 2006
Clinical Pharmacology and Biostatistics Department, Sankyo Company Ltd, Clin Pharmacokinet. 2005;44(12):1329-42.
Effect of combined treatment with an angiotensin II receptor antagonist and an HMG-CoA reductase inhibitor on atherosclerosis in genetically hyperlipidemic rabbits.
The purpose of this study was to examine whether coadministration of...
1st March, 2006
Pharmacology and Molecular Biology Research Laboratories, Sankyo Company, J Cardiovasc Pharmacol. 2005 Oct;46(4):556-62.
Improvement of single nucleotide polymorphism genotyping by allele-specific PCR using primers modified with an ENA residue.
When we placed an ENA residue into primers at the 3' end, or the n-1, n-2,...
10th September, 2005
Lead Discovery Research Laboratories, Sankyo Company Ltd., 2-58, Hiromachi Anal Biochem. 2005 May 15;340(2):287-94.
DOI Direct Link
Brain insulin impairs amyloid-beta(1-40) clearance from the brain.
Cerebral amyloid-beta peptide (Abeta) clearance plays a key role in...
20th May, 2005
Drug Metabolism and Pharmacokinetics Research Laboratories, Sankyo J Neurosci. 2004 Oct 27;24(43):9632-7.
DOI Direct Link
Evaluation of the protein binding ratio of drugs by a micro-scale ultracentrifugation method.
Ultracentrifugation methods have been widely used for the determination of...
13th November, 2004
Pharmacokinetics and Drug Delivery Research Laboratories, Sankyo Company, J Pharm Sci. 2004 Apr;93(4):847-54.
DOI Direct Link

View more Sankyo Company Limited research publications.

Press Releases on Sankyo Company Limited:

BioPortfolio Logo
Reportlinker Adds Imaging Agents - A Worldwide Market Review 20th November, 2009 Reportlinker
NEW YORK, Nov. 20 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Imaging Agents - A Worldwide Market Review http://www.reportlinker.com
New Updates to AHA/ACC/SCAI Clinical Guidelines Recommend Treatment with Effient(R) for Patients with Acute Coronary Syndromes Managed with PCI 18th November, 2009 Eli Lilly and Company
PARSIPPANY, N.J. and INDIANAPOLIS, Nov. 18 /PRNewswire-FirstCall/ -- Effient® (prasugrel) tablets, a new antiplatelet medicine, was added as a treatment option in two clinical guideline updates: one
Reportlinker Adds Antibiotics - Global Trends 18th November, 2009 Reportlinker
NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Antibiotics - Global Trends http://www.reportlinker.com/p0164263
Efient(R) Exhibited Greater Antiplatelet Activity than High Dose Clopidogrel in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease 15th November, 2009
ORLANDO, Florida, November 15 /PRNewswire/ -- Results from a new study showed patients with type 2 diabetes mellitus who also had coronary artery disease (CAD) and received a 60 mg loading dose and 10
Effient(R) Exhibited Greater Antiplatelet Activity than High Dose Clopidogrel in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease 15th November, 2009 Eli Lilly and Company
ORLANDO, Fla., Nov. 15 /PRNewswire-FirstCall/ -- Results from a new study showed patients with type 2 diabetes mellitus who also had coronary artery disease (CAD) and received a 60 mg loading dose and

BioNews Results for Sankyo Company Limited:

BioInvent Signs Licensing Agreement with Daiichi Sankyo for the Discovery and Development of Therapeutic Antib
PharmiWeb:  Nov 15 2009 3:26AM Matching: sankyo company
BioInvent Signs Licensing Agreement With Daiichi Sankyo
FDA News:  Nov 13 2009 10:37PM Matching: sankyo company
BioInvent International, Daiichi Sankyo sign licence and discovery agreement
News-Medical.Net:  Nov 13 2009 1:41PM Matching: sankyo company
BioInvent Signs Licensing Agreement with Daiichi Sankyo for the Discovery and Development of...
Forbes.com:  Nov 13 2009 8:00AM Matching: sankyo company
BioInvent Signs Licensing Agreement with Daiichi Sankyo for the Discovery and Development of Therapeutic Antibodies
Street Insider:  Nov 13 2009 7:58AM Matching: sankyo company
Promote your company here: BioNewsCast - Press Release Distribution

View more Sankyo Company Limited news.

Sankyo Company Limited Clinical Trials:

Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension

Sankyo Company Limited Patents:

US Patent No.Title
6844173 Strain of Streptomyces griseus
7030138 Benzamidine derivatives
7034150 Processes for the preparation of carbapenem-type antibacterial agents
7037934 Blood lipid ameliorant composition
7041660 Crystalline 1-methylcarbapenem derivatives

View more Sankyo Company Limited patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1118 times since April 2007, the link to the organisation's website has been followed 198 times

Recent Search Terms used to find this page: SANKYO distributions | SANKYO distributions | sankyo agriculture | SANKYO distributions | SANKYO distributions | sankyo cs-866 | sankyo cs-866 | SANKYO distributions | sankyo company agriculture | sankyo ena | .

Search for more companies in Tokyo

Search for more companies in Tokyo



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Sankyo Company Limited

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.